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Sickle Cell Disease
Vibhu Bhargava, 4th Term, DY Patil Medical College And Hospital &
Research Centre, Pimpri-Chinchwad, Maharastra ; Dr. Sandeep Barve,
Professor Of Pathology, Parul Institute Of Medical Sciences And Research,
Vadodara, Gujarat

CLINICAL HISTORY:

29 year old male patient came with the complaints of abdominal pain since 3
months, insidious in onset, non-progressive. He also gives history of low grade
fever and cough. Cough is associated with expectoration, whitish to yellowish
in color, mild in quantity, not blood tinged, not foul smelling. History of 2-3
episodes of vomiting since 1 week, non-bile tinged.
No history of joint pain, breathlessness and fatigue.
Past history: The patient is a known case of sickle cell disease diagnosed in
childhood.
He has undergone multiple blood transfusions since childhood.
No history of diabetes mellitus, hypertension, thyroid disorders or cardiac
disorders.
EXAMINATION AND INVESTIGATIONS:
General Physical Examination:
Febrile. (99.2 F)
Pallor and icterus present.
No generalised lymphadenopathy.
Systemic Examination:
Abdomen:
Inspection: Umbilicus central. No distention visible
Palpation :
Tenderness present in the epigastric region. Mild tenderness present in RUQ on
deep palpation.
Murphy’s sign negative.
Percussion: Normal. No Signs of free fluid.
Auscultation. Normal bowel sounds heard.
CVS: S1, S2 heard.No murmurs.
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RS: NVBS heard on the right side. Decreased breath sounds over the left lung.
No added sounds.
CNS: Normal.
Blood Investigations:
Hb:9.1gms/dl
Total WBC:
15,220/mcl
N:71%, L:20%
RBC:4.16 million/mcl
MCV:69.8%
MCH:21.9%
MCHC:31.4%
RDW-CV:17.5%
Platelet:53000/mcl
Peripheral Blood Smear:
Red blood cells are normocytic normochromic to mildly hypochromic.
Moderate degree of anisopoikilocytosis noted.
Sickle cells seen. (Marked in black)
(Insert Image 1)
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Solubility Sickling Test:
Positive
(Insert Image 2)
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1.
Hb analysis by HPLC
Hb A:9.8%
Hb A2: 2.9%
Hb F: 6.2%
Hb S: 81.1%
Findings are suggestive of SICKLE CELL SYNDROME.
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1.
(Insert Image 3)
X-Ray Chest (PA view)
Blunting of left costophrenic angle. s/o left pleural effusion.
(Insert image 4)
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1.
MDCT Abdomen & Pelvis:
Acute pancreatitis with intrapancreatic pseudocysts.
Cholelithiasis.
Left mild to moderate pleural effusion..
FINAL DIAGNOSIS:
SICKLE CELL DISEASE WITH PLEURAL EFFUSION AND
CHOLELITHIASIS
DISCUSSION:
NJ CEFTRIAXONE 1 GM IV x 7 days
TAB FOLVIT (Folic acid) x 5 days
TAB PANTOPRAZOLE 1-0-1 X 20 days
Pleural tapping was advised SOS.
The patient refused further interventions, hereafter.
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Sickle cell disease is a common hereditary hemoglobinopathy caused by a point
mutation in B globin that promotes the polymerisation of deoxygenated
haemoglobin leading to red cell distortion, microvascular obstruction,
haemolytic anaemia and ischemic tissue damage.1
The replacement of β6 glutamic acid with valine results in a hydrophobic
interaction of sickle hemoglobin (hemoglobin S) with another hemoglobin
molecule in conditions of low oxygen availability, trigger an aggregation into
large polymers. The polymerization of deoxygenated hemoglobin S is the
primary event in the molecular pathogenesis of sickle cell disease, resulting in a
distortion of the shape of the red cell (banana or sickle shaped) and a marked
decrease in its deformability. These rigid cells are responsible for the vasoocclusive phenomena that are the hallmark of the disease.2
SCD is caused by genetic and non-genetic factors. The genetic cause is
characterized by the presence of abnormal erythrocytes damaged by HbS, a
variant of normal adult hemoglobin (HbA), inherited either from both parents
(homozygous for the HbS gene) or with β-thalassemia (compound
heterozygosity) or from one parent, along with another hemoglobin variant,
such as hemoglobin C (HbC). The non-genetic factors include climate, air
quality, as well as socioeconomic factors. 2,3
Dactylitis is the most common initial symptom, noted in children in the first 2
years of life whereas painful crisis is the first symptom frequently seen in
patients after the age of 2 years. The most common nonspecific symptom is
pneumonia.4
Infection is a major determinant of the outcome in patients with sickle cell
disease. Splenic dysfunction has a key role in the increased susceptibility to
bacterial infections seen in children with sickle cell disease, and pneumococcal
and haemophilus infections.3
The complications of sickle cell disease are varied ranging from vaso-occlusive
crisis to acute chest syndrome, and pulmonary hypertension.5 A dreaded
complication of formation of silent infarcts due to adherence of sickle cells to
the endothelium, causing activation of the inflammatory cascade and clotting
factors resulting in in a nidus for thrombus formation can lead to severe motor
and cognitive impairment.6
Clinical outcomes have gradually improved over the years, mostly as a result of
developments in supportive care and treatment with hydroxyurea, which
stimulates hemoglobin F production.2 Penicillin prophylaxis in children,
primary stroke prevention, regular blood transfusions are main modalities of
treatment and prevention. 4
Hematopoietic stem-cell transplantation is potentially curative, although its use
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is restricted by the high cost, toxicity, and limited availability of suitable
donors.3

CONCLUSION:
We reviewed a case of a 29-year male, adult who presented with acute pain
abdomen and additional history of low grade fever . This report illustrates the
importance of having valid differentials for pain abdomen in an acute setting
and performing the required valid blood investigations.prompt treatment by
medical line of management at diagnosis to improve outcome and prevent
complications recurrent infection and vaso occlusive complications.
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